{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:31:17Z","timestamp":1790958677415,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/iae.0b013e31820039af","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T03:29:30Z","timestamp":1298604570000},"page":"1316-1322","source":"Crossref","is-referenced-by-count":26,"title":["LONG-TERM POTENCY, STERILITY, AND STABILITY OF VANCOMYCIN, CEFTAZIDIME, AND MOXIFLOXACIN FOR TREATMENT OF BACTERIAL ENDOPHTHALMITIS"],"prefix":"10.1097","volume":"31","author":[{"given":"Sachin","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassanain","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice N","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L","family":"Wayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco M","family":"Recchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sternberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210130","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2005.02.028","article-title":"The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001.","volume":"112","author":"West","year":"2005","journal-title":"Ophthalmology"},{"key":"R2-11-20210130","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00006982-200410000-00002","article-title":"Risks of intravitreous injection: a comprehensive review.","volume":"24","author":"Jager","year":"2004","journal-title":"Retina"},{"key":"R4-11-20210130","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","article-title":"Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis.","volume":"113","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R5-11-20210130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.1994.01090130058017","article-title":"Aminoglycoside Toxicity Study Group. Aminoglycoside toxicity in the treatment of endophthalmitis.","volume":"112","author":"Campochiaro","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R6-11-20210130","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.ophtha.2010.03.034","article-title":"Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections.","volume":"117","author":"Kim","year":"2010","journal-title":"Ophthalmology"},{"key":"R7-11-20210130","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/S0161-6420(03)00735-8","article-title":"Antibiotic resistance patterns of ocular bacteria flora: a prospective study of patients undergoing anterior segment surgery.","volume":"110","author":"Ta","year":"2003","journal-title":"Ophthalmology"},{"key":"R8-11-20210130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1167\/iovs.05-1124","article-title":"Clearance of intravitreal moxifloxacin.","volume":"47","author":"Iyer","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-11-20210130","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1167\/iovs.05-0702","article-title":"Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models.","volume":"47","author":"Gao","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R10-11-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006982-200602000-00011","article-title":"Intravitreal toxicity of moxifloxacin.","volume":"26","author":"Aydin","year":"2006","journal-title":"Retina"},{"key":"R11-11-20210130","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/IAE.0b013e3181733733","article-title":"Pegaptanib combined with intravitreal injection of moxifloxacin as treatment of wet macular degeneration.","volume":"28","author":"Bennett","year":"2008","journal-title":"Retina"},{"key":"R12-11-20210130","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/ajhp\/61.18.1928","article-title":"USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.","volume":"61","author":"Kastango","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"R14-11-20210130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.saa.2006.11.023","article-title":"Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations.","volume":"68","author":"Motwani","year":"2007","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"R15-11-20210130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/archopht.123.5.613","article-title":"Acute endophthalmitis following cataract surgery: a systemic review of the literature.","volume":"123","author":"Taban","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R16-11-20210130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0002-9394(03)00202-2","article-title":"Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds.","volume":"136","author":"Cooper","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R17-11-20210130","first-page":"553","article-title":"Evaluation of toxicity of intravitreal ceftazidime, vancomycin, and ganciclovir in a silicone oil-filled eye.","volume":"19","author":"Hegazy","year":"1999","journal-title":"Retina"},{"key":"R18-11-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/jop.1987.3.257","article-title":"Intravitreal ceftazidime in a rabbit model: dose- and time-dependent toxicity and pharmacokinetic analysis.","volume":"3","author":"Jay","year":"1987","journal-title":"J Ocul Pharmacol"},{"key":"R19-11-20210130","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1987.01060060117045","article-title":"Intravitreal vancomycin. Retinal toxicity, clearance, and interaction with gentamicin.","volume":"105","author":"Pflugfelder","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"R20-11-20210130","first-page":"5551","article-title":"Evaluation of antimicrobial activity of intravitreal antibiotics after prolonged storage.","volume":"46","author":"Nguyen","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-11-20210130","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ophtha.2007.05.019","article-title":"Off-label antibiotic preparation.","volume":"114","author":"Dobrinas","year":"2007","journal-title":"Ophthalmology"},{"key":"R22-11-20210130","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/ICO.0b013e3181c32573","article-title":"In vitro stability of fortified ophthalmic antibiotics stored at 20 degrees C for 6 months.","volume":"29","author":"Chedru-Legros","year":"2010","journal-title":"Cornea"},{"key":"R23-11-20210130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF02849853","article-title":"Antibacterial activity of the fourth-generation quinolones gatifloxacin and moxifloxacin against ocular pathogens.","volume":"20","author":"Callegan","year":"2003","journal-title":"Adv Ther"},{"key":"R24-11-20210130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jac\/31.5.711","article-title":"In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates.","volume":"31","author":"Unal","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"R25-11-20210130","doi-asserted-by":"crossref","first-page":"S1025","DOI":"10.1093\/clinids\/11.Supplement_5.S1025","article-title":"Synergy of fluoroquinolones with other antimicrobial agents.","volume":"11","author":"Neu","year":"1989","journal-title":"Rev Infect Dis"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e31820039af","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:53:37Z","timestamp":1786042417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201107000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31820039af","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}